2009, Number 3
<< Back Next >>
Rev Endocrinol Nutr 2009; 17 (3)
Patterns of anti-thyroglobulin antibodies in patients with differentiated thyroid carcinoma
Sosa-Caballero A, Alamilla-Lugo L, Muñoz-Solís A
Language: Spanish
References: 7
Page: 129-131
PDF size: 75.01 Kb.
ABSTRACT
The prevalence of antibodies against thyroglobulin (TgAb) in patients with differentiated thyroid carcinoma (DTC) appears to be between 8.5 and 25%. These antibodies interfere with the determination of thyroglobulin (Tg) and its value as a marker of the presence of thyroid tissue. On the other hand, the presence of TgAb and their behavior over time can be used as a marker of tumor activity. In this report we present five different clinical cases of DTC with TgAb and illustrate how their fluctuations can influence therapeutic decisions.
REFERENCES
Chung J, Park Y, Kim T et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol 2002; 57: 215-221.
Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992; 33: 1478–1480.
Phan HT, Jager PL, van der Wal JE et al. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin and Tg antibodies during ablation. Eur J Endocrinol 2008; 158: 77-83.
Spencer CA, Takeuchi M, Kazarosyan C et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121–1127.
Görges R, Maniecki M, Jentzen W et al. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 2005; 153: 49–55.
Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical Management of low risk patients with thyroid cancer with Tg on T4 < 1 ng/mL determined by traditional assays? Clin Endocrinol 2008; 68: 338-342.
Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90: 5566-5575.
Full text